Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer.

MLA

Erman, Aysegul, et al. “Cost-Effectiveness Analysis of Extended Adjuvant Endocrine Therapy in the Treatment of Post-Menopausal Women with Hormone Receptor Positive Breast Cancer.” Breast Cancer Research & Treatment, vol. 145, no. 2, June 2014, pp. 267–79. EBSCOhost, https://doi.org/10.1007/s10549-014-2950-6.

APA

Erman, A., Nugent, A., Amir, E., & Coyte, P. (2014). Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer. Breast Cancer Research & Treatment, 145(2), 267–279. https://doi.org/10.1007/s10549-014-2950-6

Chicago

Erman, Aysegul, Arlene Nugent, Eitan Amir, and Peter Coyte. 2014. “Cost-Effectiveness Analysis of Extended Adjuvant Endocrine Therapy in the Treatment of Post-Menopausal Women with Hormone Receptor Positive Breast Cancer.” Breast Cancer Research & Treatment 145 (2): 267–79. doi:10.1007/s10549-014-2950-6.